Skip to content

Combination of dexamethasone and dexmedetomidine as adjuvants of TAP block for postoperative analgesia in gastric cancer patients: A double-blinded randomized controlled trial

Combination of dexamethasone and dexmedetomidine as adjuvants of TAP block for postoperative analgesia in gastric cancer patients: A double-blinded randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037981
Enrollment
Unknown
Registered
2020-09-08
Start date
2021-09-07
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgeisa

Interventions

A group:30 ml 0.25% ropivacaine+ 5mg dexamethasone + 0.5 ug/kg dexmedetomidine (each side)
B group:30 ml 0.25% ropivacaine+ 5mg dexamethasone (each side)
C group:30 ml 0.25% ropivacaine+ 0.5 ug/kg dexmedetomidine (each side)

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients were 18 years of age or older; 2. With American Society of Anesthesiologists (ASA) physical status I–III; 3. Schedule for gastric cancer surgery under general anesthesia; 4. Inform consent signed.

Exclusion criteria

Exclusion criteria: 1. With contraindications to nerve block (e.g. infection at puncture site); 2. With difficulty for communication; 3. Body Mass Index (BMI) below 18.5 kg/m^2 or over 30 kg/m^2; 4. Preoperative examination indicating metastasis; 5. With chronic pain (last over three months) or chronic opioid use (over 60 mg of oral morphine or equivalent per day); 6. With contraindications to any drugs used in the study; 7. Participated in other clinical trials within three months.

Design outcomes

Primary

MeasureTime frame
INcidence of moderate-to-severe pain on movement at 24 h after surgery;

Secondary

MeasureTime frame
NRS score;Opioids consumption;The duration of the first rescue analgesia;Time of first getting out of bed;Time of first exhausting;Incidence of adverse events including intraoperative hypotension, intraoperative bradycardia, intraoperative hypertension, postoperative nausea and vomiting (PONV), pruritus, dizzy, respiratory depression, pulmonary infection, surgical site infection, urinary tract infection, bloodstream infection, sepsis (Septic shock);Length of hospital stay;Postoperative recovery quality;Incidence of moderate-to-severe pain;Time to gastric tube removal;Time to urine catheter removal;The proportion of first request of rescue analgesia;Incidence of moderate-to-severe pain on movement;Hospitalization cost;Incidence of chronic pain;

Countries

China

Contacts

Public ContactLi Qian

West China Hospital, Sichuan University

hxliqian@foxmail.com+86 189 8060 1635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026